# Treatment of Advanced Hodgkin's Disease (Stages IIB-III-IV)

> **NCT00443677** · PHASE3 · COMPLETED · sponsor: **Gruppo Italiano Studio Linfomi** · enrollment: 307 (actual)

## Conditions studied

- Advanced Hodgkin Disease

## Interventions

- **DRUG:** COPPEBVCAD vs BEACOPP vs ABVD

## Key facts

- **NCT ID:** NCT00443677
- **Lead sponsor:** Gruppo Italiano Studio Linfomi
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-04
- **Primary completion:** —
- **Final completion:** 2007-06
- **Target enrollment:** 307 (ACTUAL)
- **Last updated:** 2009-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00443677

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00443677, "Treatment of Advanced Hodgkin's Disease (Stages IIB-III-IV)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00443677. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*